Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Monoclonal Antibody Impact Factor

Monoclonal antibodies MAb are antibodies produced by introducing an antigen to a mouse and then fusing polyclonal B cells from the mouse's spleen to myeloma cells. The resulting hybridoma cells are cultured and continue to produce antibodies to the antigen. Many different monoclonal antibodies are already available to treat cancer. Some newer types are still in clinical trials. Different monoclonal antibodies cause different side effects. More common side effects include allergic reactions, flu like symptoms, nausea, vomiting etc., It can take a long time to develop this type of treatment because making monoclonal antibodies can be very complicated. We strongly feel this is a timely commitment and would like to invite researchers from both academia and industry to submit their novel mAb therapy work for this issue in order to capture the new developments that have transpired as well as covering established concepts in this exciting field. 

High Impact List of Articles
Conference Proceedings

Relevant Topics in Immunology & Microbiology

Get the App